Kizaki, Hayato
Yamamoto, Daisuke
Satoh, Hiroki
Masuko, Kotaro
Maki, Hideyuki
Konishi, Yukari
Hori, Satoko
Sawada, Yasufumi
Article History
Received: 7 November 2021
Accepted: 29 March 2022
First Online: 22 April 2022
Declarations
:
: This study was approved by the Research Ethics Review Committee of the Faculty of Pharmaceutical Sciences, the University of Tokyo (accession number 29–2, approved on July 3, 2017) and the Research Ethics Review Committee, Faculty of Pharmacy, Keio University (accession number 190119–1, approved on January 19, 2019). This study was conducted according to the Declaration of Helsinki. Written informed consent was obtained from all participants prior to participation. All participants were informed verbally and in writing about the study purpose and they were all assured that they could withdraw their consent at any time.
: Not required.
: Financial competing interestsKH and HS declare that they have no financial competing interests. YD, MK, MH, KY are employees of <i>SOMPO Care Inc.</i> SH and SY are researchers in a laboratory that has received a grant from <i>SOMPO Care Inc.</i>Non-financial competing interestsThe authors declare that they have no non-financial competing interests.